Tanja Saußele

1.4k total citations
13 papers, 1.1k citations indexed

About

Tanja Saußele is a scholar working on Pharmacology, Oncology and Infectious Diseases. According to data from OpenAlex, Tanja Saußele has authored 13 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 5 papers in Oncology and 4 papers in Infectious Diseases. Recurrent topics in Tanja Saußele's work include Pharmacogenetics and Drug Metabolism (7 papers), Drug Transport and Resistance Mechanisms (5 papers) and HIV/AIDS drug development and treatment (4 papers). Tanja Saußele is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Drug Transport and Resistance Mechanisms (5 papers) and HIV/AIDS drug development and treatment (4 papers). Tanja Saußele collaborates with scholars based in Germany, United States and Switzerland. Tanja Saußele's co-authors include Ulrich M. Zanger, Kathrin Klein, Matthias Schwab, Julia Blievernicht, Michel Eichelbaum, Marco H. Hofmann, Elke Schaeffeler, Thomas Lang, Eduardo Barbosa‐Sicard and Wolf‐Hagen Schunck and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Clinical Pharmacology & Therapeutics and Drug Metabolism and Disposition.

In The Last Decade

Tanja Saußele

13 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tanja Saußele Germany 9 606 454 316 268 178 13 1.1k
Julia Blievernicht Germany 10 593 1.0× 365 0.8× 510 1.6× 212 0.8× 170 1.0× 10 1.3k
Manoli Vourvahis United States 21 334 0.6× 502 1.1× 444 1.4× 262 1.0× 277 1.6× 55 1.4k
Bryan A. Ward United States 7 677 1.1× 450 1.0× 392 1.2× 252 0.9× 141 0.8× 8 1.4k
Lisa M. Almond United Kingdom 17 327 0.5× 381 0.8× 324 1.0× 199 0.7× 259 1.5× 34 1.1k
Joy A. Nishime United States 11 316 0.5× 229 0.5× 283 0.9× 140 0.5× 161 0.9× 14 690
John Tjia United Kingdom 17 332 0.5× 725 1.6× 203 0.6× 452 1.7× 236 1.3× 23 1.3k
Bradley M. Kerr United States 16 375 0.6× 285 0.6× 226 0.7× 145 0.5× 366 2.1× 24 1.4k
Heike Tegude Germany 8 328 0.5× 185 0.4× 360 1.1× 107 0.4× 176 1.0× 9 704
Stephanie Faucette United States 14 984 1.6× 192 0.4× 571 1.8× 71 0.3× 229 1.3× 26 1.6k
Niresh Hariparsad United States 18 467 0.8× 189 0.4× 355 1.1× 63 0.2× 194 1.1× 37 974

Countries citing papers authored by Tanja Saußele

Since Specialization
Citations

This map shows the geographic impact of Tanja Saußele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tanja Saußele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tanja Saußele more than expected).

Fields of papers citing papers by Tanja Saußele

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tanja Saußele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tanja Saußele. The network helps show where Tanja Saußele may publish in the future.

Co-authorship network of co-authors of Tanja Saußele

This figure shows the co-authorship network connecting the top 25 collaborators of Tanja Saußele. A scholar is included among the top collaborators of Tanja Saußele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tanja Saußele. Tanja Saußele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Saußele, Tanja. (2015). [PCSK9 inhibitors. A new approach for treatment of hypercholesterolemia].. PubMed. 38(7). 250–7. 1 indexed citations
2.
Saußele, Tanja. (2014). [50 years of cytochrome P450. Drug metabolism - from past to present].. PubMed. 37(8). 295–8. 2 indexed citations
3.
Hofmann, Marco H., Julia Blievernicht, Kathrin Klein, et al.. (2008). Aberrant Splicing Caused by Single Nucleotide Polymorphism c.516G>T [Q172H], a Marker of CYP2B6*6, Is Responsible for Decreased Expression and Activity of CYP2B6 in Liver. Journal of Pharmacology and Experimental Therapeutics. 325(1). 284–292. 172 indexed citations
4.
Saußele, Tanja. (2008). [Lacosamide. A new antiepileptic drug as adjunctive therapy in patients with partial-onset seizures].. PubMed. 31(10). 374–7. 4 indexed citations
5.
Saußele, Tanja. (2008). [Supplementation with folic acid before and during pregnancy].. PubMed. 31(12). 469–72. 2 indexed citations
6.
Klein, Kathrin, Sebastian Raimundo, Tanja Saußele, et al.. (2007). A Natural Variant of the Heme-Binding Signature (R441C) Resulting in Complete Loss of Function of CYP2D6. Drug Metabolism and Disposition. 35(8). 1247–1250. 17 indexed citations
7.
Rotger, Margalida, Heike Tegude, Sara Colombo, et al.. (2007). Predictive Value of Known and Novel Alleles of CYP2B6 for Efavirenz Plasma Concentrations in HIV-infected Individuals. Clinical Pharmacology & Therapeutics. 81(4). 557–566. 208 indexed citations
8.
Zanger, Ulrich M., Kathrin Klein, Tanja Saußele, et al.. (2007). PolymorphicCYP2B6: Molecular Mechanisms and Emerging Clinical Significance. Pharmacogenomics. 8(7). 743–759. 196 indexed citations
9.
Saußele, Tanja, Oliver Burk, Julia Blievernicht, et al.. (2007). Selective Induction of Human Hepatic Cytochromes P450 2B6 and 3A4 by Metamizole. Clinical Pharmacology & Therapeutics. 82(3). 265–274. 50 indexed citations
10.
Desta, Zeruesenay, Tanja Saußele, Bryan A. Ward, et al.. (2007). Impact of CYP2B6 Polymorphism on Hepatic Efavirenz Metabolismin Vitro. Pharmacogenomics. 8(6). 547–558. 183 indexed citations
11.
Klein, Kathrin, Julia Blievernicht, Elke Schaeffeler, et al.. (2006). Impaired expression of CYP2D6 in intermediate metabolizers carrying the *41 allele caused by the intronic SNP 2988G>A: evidence for modulation of splicing events. Pharmacogenetics and Genomics. 16(10). 755–766. 73 indexed citations
12.
Klein, Kathrin, Thomas Lang, Tanja Saußele, et al.. (2005). Genetic variability of CYP2B6 in populations of African and Asian origin: allele frequencies, novel functional variants, and possible implications for anti-HIV therapy with efavirenz. Pharmacogenetics and Genomics. 15(12). 861–873. 211 indexed citations
13.
Saußele, Tanja, et al.. (2005). Recombinant Production of Human Microsomal Cytochrome P450 2D6 in the Methylotrophic Yeast Pichia pastoris. ChemBioChem. 6(11). 2014–2022. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julia Blievernicht Breakdown of academic impact, for papers by Manoli Vourvahis Breakdown of academic impact, for papers by Bryan A. Ward Breakdown of academic impact, for papers by Lisa M. Almond Breakdown of academic impact, for papers by Joy A. Nishime Breakdown of academic impact, for papers by John Tjia Breakdown of academic impact, for papers by Bradley M. Kerr Breakdown of academic impact, for papers by Heike Tegude Breakdown of academic impact, for papers by Stephanie Faucette Breakdown of academic impact, for papers by Niresh Hariparsad
Rankless by CCL
2026